Anticonvulsants and anxiolytics: Barbiturates
Introduction0:00–0:27
Barbiturates are a class of medications that are used as anti-convulsants to manage seizure disorders, to induce anesthesia in surgical procedures, and to reduce tremors.
Barbiturates enhance the effect of gamma aminobutyric acid or GABA, which is the major inhibitory neurotransmitter in the brain by binding to its receptor.
It's pretty well established that your brain's really important. It controls your feelings, your movements, your sleep, your memory.
Physiology0:27–1:44
It controls everything, whether you're aware of it or not. The cells that make up our brain are called neurons.
Neurons communicate with each other through neurotransmitters. When one neuron is stimulated, it will release excitatory neurotransmitters like glutamate, which bind to receptors on the next neuron.
This causes the next neuron to depolarize and release its own excitatory neurotransmitters propagating the signal throughout the brain.
Now we also have inhibitory neurons that will shut down this chain of events. These neurons release the main inhibitory neurotransmitter, gamma immunobutyric acid or GABA, which binds to GABA receptors on other neurons.
GABA A receptors specifically are large multi-subunit complexes that form ligand-gated ion channels in the cell membrane that open up, letting chloride ions into the cell.
The influx of negatively charged ions causes hyperpolarization, meaning the cell's membrane potential becomes more negative, reducing the ability of a stimulus to depolarize the membrane enough to reach the threshold needed to trigger another action potential, slowing down or stopping communication to the next neuron.
Pathology1:44–2:09
Now, there are cases where neurons in the brain start sending out more excitatory signals than normal. This can occur due to either too much excitation by the excitatory neurotransmitters or too little inhibition by the inhibitory neurotransmitters like GABA.
Excessive excitatory signals can cause psychiatric disorders like anxiety and neurological disorders like seizures. OK, so one way we can decrease the excitatory signals is by enhancing the effect of inhibitory neurons by using medications like barbiturates.
Mechanism of Action2:09–5:05
They are derived from barbituic acid, a six-membered ring structure composed of urea and melonic acid. Barbiturates are grouped by their duration of action into short acting such as pentobarbital and sicobarbital, intermediate acting such as amobarbital and apobarbital, and long acting such as phenobarbital and primidone, which is a prodrug of phenobarbital.
Barbiturates target the GABAA receptors, but they bind at a different site than GABA or benzodiazepines. At lower doses, barbiturates enhance the effect of GABA by increasing the duration of chlorine channels opening, thereby increasing the influx of chlorine ions.
As a result, higher intracellular concentrations of chlorine ions amplify membrane hyperpolarization, meaning the membrane potential will be more negative, making it even harder for a stimulus to depolarize the membrane enough to reach the threshold needed to trigger another action potential.
So barbiturates increase GABA's role in slowing down communication between neurons and calming the nervous system. Similarly, benzodiazepines also work by binding to GABA receptors, but in contrast to barbiturates, they increase the frequency of chlorine channels opening, meaning the channels open more often rather than staying open longer.
At higher doses, barbiturates can mimic GABA's effect by triggering the opening of these channels even without GABA. Now let's draw a chart of the dose dependent effects of barbiturates.
On the left side of the chart, let's place central nervous effects, and on the bottom, let's place dose. Low doses of barbiturates can cause sedation, disinhibition, and anxiolysis, but as the dose increases, barbiturates cause hypnosis, anesthesia, significant respiratory depression, and eventually coma.
Most barbiturates are metabolized in the liver through two phases. Phase one involves oxidation by CYP 450 enzymes, which produces inactive metabolites.
Next, phase 2 involves conjugation of these metabolites into water soluble compounds that are either excreted in the urine or bile.
However, it is important to note that phenobarbital is an exception since it is mostly excreted in the urine unchanged, with only a small amount undergoing liver metabolism.
Now, unlike benzodiazepines, barbiturates induce CYP 450 enzymes. These liver enzymes are involved in the metabolism of various medications like benzodiazepines, phenytoin, quinidine, warfarin, and others.
Indications5:05–5:58
Increased cytochrome P450 activity can cause these medications to break down more rapidly, so larger doses may be needed to achieve a therapeutic effect.
Alright, now barbiturates are indicated when the neurons get super excited and we want to calm them down, like during a seizure where clusters of neurons in the brain start firing off a ton of excitatory signals.
Although barbiturates are now rarely used for most types of seizures because of sedation, they are first line therapy for neonatal convulsions.
In addition, barbiturates can be used for preoperative sedation and to induce anesthesia since we basically want to depress the function of the person's nervous system.
Primidone can be used to reduce tremor activity in people with essential tremor when beta blockers can't be used or have not helped.
Finally, in life-threatening conditions such as increased intracranial pressure, these medications can be used to decrease cerebral blood flow and induce coma, which is also known as the barbiturate-induced coma.
Side Effects and Contraindications5:58–9:04
Moving on to side effects, barbiturates can have severe adverse effects even when used at therapeutic levels. They can cause drowsiness, as well as a decrease in concentration, problem solving ability, and reaction time, so it's important not to drive while taking these medications.
Also, when combined with alcohol or other medications that depress the nervous system like benzodiazepines, the depressive effects are additive and can get so severe it can cause coma.
Despite being a central nervous system depressant, in some people, barbiturates can cause paradoxical stimulation, leading to symptoms like fast speech, excitement, and restlessness.
All right, moving on. Barbiturate toxicity is associated with respiratory depression, cardiovascular collapse, coma, and even death.
The first step in treatment is to provide respiratory and cardiovascular support. The next step is to administer oral activated charcoal to bind any drug remaining in the GI tract and prevent further absorption.
And if the drug is phenobarbital, which is a weak acid, treat with sodium bicarbonate. Recall that phenobarbital is mostly excreted unchanged in the urine, so by giving sodium bicarbonate, we make a basic environment in the urine, trapping phenobarbital and increasing its excretion.
It's important to note that barbiturate toxicity can't be treated with flumazanil, which is an antidote used in benzodiazepine toxicity.
Since barbiturates are metabolized in the liver or eliminated unchanged in the urine, they should be used with caution in individuals with hepatic or renal impairment.
While in individuals with cardiovascular conditions, barbiturates are associated with an increased risk of cardiovascular depression.
Finally, as far as contraindications go, barbiturates should not be used in individuals with porphyria, such as acute intermittent porphyria or AIP.
Let's put it this way. Here is a normal heme synthesis pathway.
Now, barbiturates stimulate heme synthesis by inducing the enzyme aminolevulinic acid synthase, or ALA synthase for short.
But since individuals with acute intermittent porphyria have a deficiency of the enzyme porphobylinenogen DMinase or PBGDMinase for short, heme synthesis is decreased.
Instead, intermediate products, delta amino levulinic acid and porphobylinenogen accumulate in the liver and trigger symptoms such as severe abdominal pain and vomiting.
Finally, barbiturates should be avoided during pregnancy and breastfeeding. When used chronically, a person can develop tolerance to barbiturates, meaning the medication's effectiveness is reduced and the dose will need to be increased to get the same effects.
Chronic use can lead to dependence, which means when the medication is discontinued, the person will experience withdrawal symptoms.
Memory Palace9:04–11:41
These symptoms are similar to alcohol withdrawal and include anxiety, tremors, tachycardia, hypertension, agitation, delirium, and life-threatening seizures.
In this case, treatment is supportive and symptoms can be lessened with benzodiazepines. All right, as a quick recap, barbiturates can be used as an anti-convulsant, anesthetic, or to treat tremors.
They work on GABA receptors by increasing the duration of chlorine channels opening, thus depressing the nervous system.
Barbiturates can induce cytochrome P450 enzymes, resulting in increased metabolism of various medications like benzodiazepines, phenytoin, warfarin, and others.
Barbiturate toxicity is dangerous because it can cause life-threatening respiratory depression and cardiovascular collapse.
When they are used for a long time, individuals may experience tolerance, dependence, And substance use disorder. Now for a bonus, even though benzodiazepines and barbiturates can sometimes be used to treat the same conditions, they differ in important ways.
Let's do a quick side by side comparison. Starting with mechanism, benzodiazepines increase the frequency of chloride channel opening, whereas barbiturates increase the duration of their opening.
One makes the channel open more often, while the other makes it stay open longer. Next, benzodiazepines do not directly activate GABA receptors, meaning they require GABA to also be present, while barbiturates can directly activate the GABA receptors at high doses.
Moving on to the overdose risk, benzodiazepines are less likely to cause lethal overdose when used alone because of their ceiling effect, whereas barbiturates carry a much higher overdose risk because they do not have the ceiling effect.
Both classes have potential for abuse, but it is generally higher with barbiturates. It's also important to note that withdrawal from both can be life threatening and may cause seizures.
Finally, in an overdose, benzodiazepines have a specific reversal agent, flumazinil, whereas barbiturates do not have a specific antidote.
Review11:41–12:32
Mind Map12:32–11:24
- "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
- "Rang and Dale's Pharmacology" Elsevier (2019)
- "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
- "Does bright light have an anxiolytic effect? - an open trial" BMC Psychiatry (2007)
- "The use of phenobarbital and other anti-seizure drugs in newborns" Seminars in Fetal and Neonatal Medicine (2017)
- "Pediatric Epilepsy" Demos Medical Pub (2001)
- "Comparison of the effectiveness of phenobarbital, mephobarbital, primidone, diphenylhydantoin, ethotoin, metharbital, and methylphenylethylhydantoin in motor seizures" Clinical Pharmacology & Therapeutics (1962)
No notes for this video yet
Try adding a note below